Analyst Research Report Snapshot

Title:

CRESTON - BUSY PITCHING

Price:

$10.00

Provider:

Edison Investment Research

Date:

29 Jul 2013

Pages:

3

Type:

AcrobatPDF

Companies referenced:

CRCRE.L

Available for Immediate Download
Summary:

Creston’s Q1 IMS indicates an encouraging level of new business wins and pitching activity across both Communications and Health divisions, with the first contract now on board under the new Government Procurement Service (GPS) roster arrangement. As anticipated, Q113 revenues softened 5%, reflecting the ending of the Sanofi business. Insight continues to recover and our combined group forecasts are unchanged. Creston shares trade at an over-large discount of 28% to the agency peer group on a calendar 13 EV/EBITDA basis.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.